Anti-NCAM Reference Antibody (lorvotuzumab mertansine) CHB281
Specifications
| 100 μg / 1 mg |
Description:
Lorvotuzumab mertansine is an ADC consisting of an NCAM-directed antibody and DM1, a potent derivative of maytansine, used for the study of several solid tumors and hematological tumors.
Product type:
Antibody
Host:
CHO
Target name:
NCAM
Target species:
Human
Isotype:
IgG
Buffer:
100 mM Pro-Ac 20 mM Arg pH5.0
Applications:
ELISA、FACS、Kinetics (BLI)、Kinetics (SPR)、Functional assay
More info:
Email: info@sobekbio.com
Orders:
Email: orders@sobekbio.com



As a national high-tech enterprise, KMD Bioscience focuses on providing cell line construction and screening, natural protein extraction and fermentation, customized recombinant protein expression, monoclonal and polyclonal antibody development, phage display library construction and screening services to scientists and research institutions worldwide. At the same time, based on the company's four core technology platforms, they have successfully developed numerous recombinant proteins, antibodies, antibody drug target proteins, industrial enzymes, diagnostic materials and other related reagents for scientific research.